ML352

Catalog No. :
ACZGDM297
CAS No. :
1649450-12-3
Molecular Formula :
C21H29N3O4
Molecular Weight :
387.48

IUPAC Name:N-((3-isopropylisoxazol-5-yl)methyl)-4-methoxy-3-((1-methylpiperidin-4-yl)oxy)benzamide

ML352 structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg97%$113.00Login to see priceInquiryInquiry
10mg97%$189.00Login to see priceInquiryInquiry
25mg97%$404.00Login to see priceInquiryInquiry
50mg97%$652.00Login to see priceInquiryInquiry
100mg97%$914.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameML352
IUPAC NameN-((3-isopropylisoxazol-5-yl)methyl)-4-methoxy-3-((1-methylpiperidin-4-yl)oxy)benzamide
MDL No.MFCD28975158
Molecular FormulaC21H29N3O4
Molecular Weight387.48
SMILESO=C(NCC1=CC(C(C)C)=NO1)C2=CC=C(OC)C(OC3CCN(C)CC3)=C2
InChI KeyWBLVOWHFRUAMCP-UHFFFAOYSA-N
SynonymML352;CS-1661;VU-0476201;VU-0476201;CS-1661;ML-352;Benzamide, 4-methoxy-N-[[3-(1-methylethyl)-5-isoxazolyl]methyl]-3-[(1-methyl-4-piperidinyl)oxy]-;4-methoxy-3-[(1-methylpiperidin-4-yl)oxy]-N-{[3-(propan-2-yl)-1,2-oxazol-5-yl]methyl}benzamide;N-((3-Isopropylisoxazol-5-yl)methyl)-4-methoxy-3-((1-methylpiperidin-4-yl)oxy)benzamide , ML352;Choline Transporter Inhibitor II, ML352
CAS No.1649450-12-3
PubChem CID70679283

Synthetic Route by SureRoute

1. ACZGDM297 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZGDM297 route product structure diagram
    ACZGDM2971649450-12-3
Inquiry

2. ACZGDM297 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZGDM297 route product structure diagram
    ACZGDM2971649450-12-3
Inquiry

Comments (0)